Background: SARS-CoV-2, the causal agent of COVID-19, enters human cells using the ACE2 (angiotensin-converting enzyme 2) protein as a receptor. ACE2 is thus key to the …
O Elbasan, F Bayram, CD Yazan, T Apaydın… - PloS one, 2023 - journals.plos.org
Background The renin-angiotensin-aldosterone system was shown to be activated in severe COVID-19 infection. We aimed to investigate the relationship between angiotensin …
Innovative techniques such as the “omics” can be a powerful tool for the understanding of intracellular pathways involved in homeostasis maintenance and identification of new …
P Vinod, V Krishnappa, W Rathell Jr, G Dogbey… - Cardiology, 2024 - karger.com
Abstract Introduction: Angiotensin-converting enzyme 2 (ACE2) of the renin-angiotensin- aldosterone system (RAAS) serves as a functional receptor to gain entry into the cells for …
Background Renin–angiotensin–aldosterone system (RAAS) is hypothesized to be in the center of COVID pathophysiology as the angiotensin converting enzyme 2 (ACE2) …
M Chemaly, R McAllister, A Peace, AJ Bjourson… - Atherosclerosis plus, 2022 - Elsevier
Background and aims TACE/ADAM17 is a membrane bound metalloprotease, which cleaves substrates involved in immune and inflammatory responses and plays a role in …
E Demirci, B Çalapkorur, S Karaçavuş… - European Review for …, 2022 - europeanreview.org
OBJECTIVE: Serum ACE2 level in the acute phase of ST-segment elevation myocardial infarction may be an indicator of heart failure, however, limited studies have reported …
W Leowattana, T Leowattana… - World journal of clinical …, 2022 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a widespread outbreak since December 2019. The SARS-CoV-2 infection-related illness has …